Lcnb Corp reports 2.64% decrease in ownership of AMGN / Amgen Inc.

Amgen Inc.

MX ˙ BMV ˙ NL0000888691

Security	MX:AMGN / Amgen Inc.
Institution	Lcnb Corp
Latest Disclosed Ownership	6,685 shares
Latest Disclosed Value	$ 2,352,117

On May 11, 2026 - Lcnb Corp filed a 13F-HR form disclosing ownership of 6,685 shares of Amgen Inc. (MX:AMGN) valued at $2,352,117 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 6,866 shares of Amgen Inc.. This represents a change in shares of -2.64% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-11	2026-03-31	13F	Amgen	Common Stock	031162100	6,685	-181	-2.64	2,352	4.67	0.7790
2026-02-10	2025-12-31	13F	Amgen	Common Stock	031162100	6,866	-16	-0.23	2,247	15.71	0.7530
2025-11-10	2025-09-30	13F	Amgen	Common Stock	031162100	6,882	-225	-3.17	1,942	-2.12	0.6795
2025-08-11	2025-06-30	13F	Amgen	Common Stock	031162100	7,107	92	1.31	1,984	-9.20	0.6981
2025-05-12	2025-03-31	13F	Amgen	Common Stock	031162100	7,015	-75	-1.06	2,186	18.30	0.8046
2025-02-11	2024-12-31	13F	Amgen	Common Stock	031162100	7,090	-32	-0.45	1,848	-19.49	0.6738
2024-11-12	2024-09-30	13F	Amgen	Common Stock	031162100	7,122	-47	-0.66	2,295	2.46	0.8128
2024-08-14	2024-06-30	13F	Amgen	Common Stock	031162100	7,169	-95	-1.31	2,240	8.43	0.8367
2024-05-10	2024-03-31	13F	Amgen	Common Stock	031162100	7,264	-50	-0.68	2,065	-1.95	0.7472
2024-02-12	2023-12-31	13F	Amgen	Common Stock	031162100	7,314	36	0.49	2,107	7.67	0.8283
2023-11-13	2023-09-30	13F	Amgen	Common Stock	031162100	7,278	-248	-3.30	1,956	17.13	0.8653
2023-08-14	2023-06-30	13F	Amgen	Common Stock	031162100	7,526	427	6.01	1,671	-2.68	0.7127
2023-05-03	2023-03-31	13F	Amgen	Common Stock	031162100	7,099	395	5.89	1,716	-2.50	0.7763
2023-02-10	2022-12-31	13F	Amgen	Common Stock	031162100	6,704	491	7.90	1,761	25.71	0.8175
2022-11-14	2022-09-30	13F	Amgen	Common Stock	031162100	6,213	26	0.42	1,400	-6.98	0.7608
2022-08-12	2022-06-30	13F	Amgen	Common Stock	031162100	6,187	45	0.73	1,505	1.35	0.7802
2022-05-13	2022-03-31	13F	Amgen	Common Stock	031162100	6,142	301	5.15	1,485	13.01	0.6978
2022-02-14	2021-12-31	13F	Amgen	Common Stock	031162100	5,841	316	5.72	1,314	11.83	0.6006
2021-11-12	2021-09-30	13F	Amgen	Common Stock	031162100	5,525	80	1.47	1,175	-11.45	0.5932
2021-08-13	2021-06-30	13F	Amgen	Common Stock	031162100	5,445	200	3.81	1,327	1.69	0.6677
2021-05-13	2021-03-31	13F	Amgen	Common Stock	031162100	5,245	133	2.60	1,305	11.06	0.7113
2021-02-12	2020-12-31	13F	Amgen	Common Stock	031162100	5,112	0	0.00	1,175	-9.55	0.6658
2020-11-12	2020-09-30	13F	Amgen	Common Stock	031162100	5,112	-25	-0.49	1,299	7.18	0.8491
2020-08-12	2020-06-30	13F	Amgen	Common Stock	031162100	5,137	-78	-1.50	1,212	14.66	0.8187
2020-05-11	2020-03-31	13F	Amgen	Common Stock	031162100	5,215	615	13.37	1,057	-4.69	0.8253
2020-02-10	2019-12-31	13F	AMGEN	Common Stock	031162100	4,600	90	2.00	1,109	27.03	0.6769
2019-11-08	2019-09-30	13F	AMGEN	Common Stock	031162100	4,510	133	3.04	873	8.18	0.5594
2019-08-01	2019-06-30	13F	AMGEN	Common Stock	031162100	4,377	116	2.72	807	-0.37	0.5665
2019-05-02	2019-03-31	13F	AMGEN	Common Stock	031162100	4,261	360	9.23	810	6.72	0.5862
2019-02-19	2018-12-31	13F	AMGEN	Common Stock	031162100	3,901	9	0.23	759	-5.95	0.6263
2018-11-09	2018-09-30	13F	AMGEN	Common Stock	031162100	3,892	-77	-1.94	807	10.10	0.5702
2018-08-13	2018-06-30	13F	AMGEN	Common Stock	031162100	3,969	955	31.69	733	42.88	0.6618
2018-05-15	2018-03-31	13F	AMGEN	Common Stock	031162100	3,014	40	1.34	513	-0.77	0.4614
2018-02-13	2017-12-31	13F	AMGEN	Common Stock	031162100	2,974	-5	-0.17	517	-7.01	0.4553
2017-11-13	2017-09-30	13F	AMGEN	Common Stock	031162100	2,979	147	5.19	556	13.93	0.5219
2017-08-14	2017-06-30	13F	AMGEN	Common Stock	031162100	2,832	-6	-0.21	488	4.72	0.4770
2017-05-12	2017-03-31	13F	AMGEN	Common Stock	031162100	2,838	-9	-0.32	466	12.02	0.4456
2017-02-14	2016-12-31	13F	AMGEN	Common Stock	031162100	2,847	2,847		416		0.4110

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.